Quality Control– tag –
-
Market Trends
Repligen Acquires BioLife Solutions for ~$1.5B, Expanding Cell Therapy Services; Beone Medicines Invests $300M in US Manufacturing Expansion
Endpoints News USA Overview Repligen has announced the acquisition of cell processing service provider BioLife Solutions for approximately $1.5 billion, significantly broadening its capabilities within the cell therapy sector. Concurrent... -
Cell Culture Technology
Sartorius Accelerates Cell & Gene Therapy Commercialization with Comprehensive End-to-End Solutions
Sartorius Germany Overview Sartorius emphasizes its mission to accelerate the commercialization of cell and gene therapies (CGT) by providing end-to-end solutions that deliver reproducible performance and scalability. Its portfolio suppo... -
Market Trends
Creative Life Science Unveils PIC/S GMP-Compliant Cell Therapy Platform at BIO Asia-Taiwan 2026, Bolstered by New Taiwan Regenerative Medicine Laws
PR Newswire Taiwan Overview According to PR Newswire, Creative Life Science is showcasing its PIC/S GMP-compliant cell therapy materials and manufacturing platform at BIO Asia-Taiwan 2026. The company's Zhubei biomanufacturing facility s... -
Market Trends
Japan Prioritizes Quality in ‘China Plus One’ CDMO Strategy with Over $4 Billion Investment by FUJIFILM Diosynth and Others
BioProcess International USA Overview A BioProcess International article analyzes the 'China Plus One' strategy and biomanufacturing capacity in the APAC region. FUJIFILM Diosynth Biotechnologies has committed over $4 billion to global e... -
Cell Culture Technology
FUJIFILM Cellular Dynamics Opens iPSC Manufacturing Facility, Made Scientific & Pluristyx Announce iPSC Partnership Expansion
openPR.com USA Overview According to openPR.com, FUJIFILM Cellular Dynamics opened a new iPSC development and manufacturing facility in Madison in May 2026, significantly expanding its induced pluripotent stem cell production capacity. F... -
Cell Culture Technology
Thermo Fisher Scientific Explains How PAT Enables Real-Time Quality Control in Pharmaceutical Manufacturing, With AI Transforming Data into Actionable Insights
Thermo Fisher Scientific (Behind the Bench) USA Overview Thermo Fisher Scientific elucidates how Process Analytical Technology (PAT) facilitates real-time quality control across diverse pharmaceutical modalities, including biologics, mRN... -
Market Trends
BioPharma APAC Discusses AI Implementation in GMP Facilities and Audit Trail Imperatives: Singapore Automates Digital Twin for Fault Detection
BioPharma APAC Singapore Overview BioPharma APAC examines the current state and challenges of AI implementation in GMP facilities, showcasing applications like predictive maintenance, machine vision QC, and AI-assisted investigations. Th... -
Market Trends
Gyros Protein Technologies Streamlines Biotherapeutic Impurity Testing with Automated Immunoassay Platform: Enhancing Reproducibility and Throughput
Bioprocess International (via Gyros Protein Technologies webcast summary) USA Overview Gyros Protein Technologies is addressing impurity testing challenges in biotherapeutic development with its Gyrolab automated immunoassay platform. Th... -
Cell Culture Technology
Securecell Unveils APIES Multi-Attribute Analysis Platform for Biopharmaceuticals: Real-time Monitoring of Protein Concentration, Aggregation, and Stability
Securecell Switzerland Overview Securecell has launched APIES, a multi-attribute analysis platform providing comprehensive insights into biopharmaceutical samples. APIES leverages absorbance, intrinsic fluorescence, and scattering to ena... -
Market Trends
6th iPSC Drug Development Summit to Address GMP Scale-Up Challenges, Focusing on Gene Editing Safety and QC Frameworks
BioInsights International Overview The 6th iPSC Drug Development Summit will primarily focus on challenges associated with scaling iPSC platforms to GMP standards. Key discussions will cover implementing GMP-compatible gene editing strat...